Grifols: Reassuring Evidence, Still On The Sidelines
2025-07-18 07:05:40 ET
We return to Grifols ( GRFS ) with a fresh review, following our previously neutral stance, which reflected a balance of encouraging progress and lingering concerns. As a reminder, we reported many question marks , and even if the company's leverage and governance concerns were addressed, we still saw a red flag on negligible FCF generation. While Grifols' share price has rebounded (Fig. 1) — highlighting a missed opportunity on our part — we believe it's still appropriate to note the ongoing presence of short-seller scrutiny and unresolved litigation risks ....
Read the full article on Seeking Alpha
For further details see:
Grifols: Reassuring Evidence, Still On The SidelinesNASDAQ: GIKLY
GIKLY Trading
0.0% G/L:
$6.74 Last:
100 Volume:
$6.74 Open:



